Challenging Presentations in Major Depressive Disorder CME/CE

Author Information and Disclosures

Release Date: September 30, 2008Valid for credit through September 30, 2009

Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s) for physicians;
Nurses - 1.0 ANCC contact hours (0.5 contact hours are in the area of pharmacology);
Pharmacists - 1.0 ACPE continuing education credits for pharmacists (0.1 CEUs)

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Contents of This CME/CE Activity

    Courtney S. - This 22-year-old woman has a 6-year history of eating disorder and one episode of superficial wrist cutting at age 17.

    Alan A. - This 36-year-old male alcoholic has not used any substance for 3 months and is into his third episode of depression over the past 3 years.

    Annie H. - This 57-year-old African American woman with 25 years of depression symptoms, probable fibromyalgia, and sleep disorder has seen numerous medical doctors.

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 Medscape.


BMS, Otsuka

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Relate an appropriate diagnosis of major depressive disorder (MDD), both single-episode as well as recurrent, differentiating it from bipolar disorder and other conditions
  2. Recognize clinical features, ordered depression rating scales, and disability scales to gauge the progress of antidepressants from various classes in order to recognize an inadequate response, with the concomitant need for changes in the treatment regimen
  3. Describe new strategies, such as adjunctive antipsychotic therapy, in the management of MDD
Authors and Disclosures

Andrew A. Nierenberg, MD
Disclosure: Andrew A. Nierenberg, MD, has disclosed that he has served as an advisory board consultant to Appliance Computing, AstraZeneca, BrainCells, Bristol-Myers Squibb, EpiQ, Eli Lilly, Jazz Pharmaceuticals, Merck, NIMH, Novartis, PGX Health, Schering-Plough, Shire, Takeda, and Targacept. Dr. Nierenberg has also disclosed that he has received research support from Pam Labs, Forest Pharmaceuticals, NIMH, Pfizer, and Shire.


Laurie E. Scudder, MS, NP-C
Disclosure: Laurie E. Scudder, MS, NP-C, has disclosed that she has no relevant financial relationships.


Jane Lowers
Disclosure: Jane Lowers has disclosed no relevant financial relationships.


David Danar, MD
Disclosure: David Danar has disclosed that he owns a small quantity of Pfizer Inc stock.


 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

Medscape is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Awarded 1.0 contact hour(s) of continuing nursing education for RNs and APNs; 0.5 contact hours are in the area of pharmacology.

Contact This Provider

 
ACPE logoMedscape is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Medscape designates this continuing education activity for 1.0 contact hour(s) (0.10 CEUs) (Universal Program Number 461-000-08-060-H01-P).

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.